Financials

  • Market Capitalization 3.23 B
  • Employee 145
  • Founded 2015
  • CEO N/A
  • Website www.ideayabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00CTZ4D83
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-21.22
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1618
DYN
Dyne Therapeutics, Inc. - Common Stock
23.99 USD+0.88%+1.01%+30.88%+2.48%3.43 B USD
1650
ELVN
Enliven Therapeutics, Inc. - Common Stock
53.16 USD+2.76%+4.38%+24.94%+157.31%3.24 B USD
1664
BEAM
Beam Therapeutics Inc. - Common Stock
30.84 USD-0.16%-15.81%-0.68%+53.28%3.17 B USD
1680
RARE
Ultragenyx Pharmaceutical Inc. - Common Stock
31.71 USD-1.00%-8.64%+26.39%+15.90%3.12 B USD

Frequently asked questions about IDEAYA Biosciences, Inc. - Common Stock

What is the IDEAYA Biosciences, Inc. - Common Stock stock price today?

The current price of IDEAYA Biosciences, Inc. - Common Stock (IDYA) is 36.74. Over the past 24 hours, the stock has changed by +0.25%. Follow the IDYA chart for real-time price dynamics.

What is the stock ticker of IDEAYA Biosciences, Inc. - Common Stock?

IDEAYA Biosciences, Inc. - Common Stock trades under the ticker IDYA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is IDEAYA Biosciences, Inc. - Common Stock stock going up?

IDYA has changed by -2.60% over the last week, +19.36% over the last month, and +12.77% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was IDEAYA Biosciences, Inc. - Common Stock net income for the last quarter?

IDEAYA Biosciences, Inc. - Common Stock reported net income of -98.54 M for the last quarter. The previous quarter showed -83.27 M, which means net income changed by -18.33%.

How many employees does IDEAYA Biosciences, Inc. - Common Stock have?

As of the latest available data, IDEAYA Biosciences, Inc. - Common Stock has 145 employees. Workforce size can provide additional context about the company's scale and operations.

What is IDEAYA Biosciences, Inc. - Common Stock EBITDA?

IDEAYA Biosciences, Inc. - Common Stock EBITDA is -107.86 M, and its EBITDA margin is -1 644.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy IDEAYA Biosciences, Inc. - Common Stock stock?

You can buy IDEAYA Biosciences, Inc. - Common Stock (IDYA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in IDEAYA Biosciences, Inc. - Common Stock stock?

Investing in IDEAYA Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IDYA chart and related analysis on metatrader.com as part of your research.

News